Company

Omniscient Neurotechnology Pty Limited

Omniscient Neurotechnology develops AI tools for mapping brain connectivity and supporting clinical care.

About

Omniscient Neurotechnology develops Quicktome, an AI platform that analyzes brain connectivity to support treatment planning for neurological conditions. Founded in 2019, the company is based in Sydney, Australia, and was co-founded by Michael Sughrue, Stephane Doyen, and Stephen Scheeler. It raised USD 27.2 million in Series D funding in June 2026, co-led by OIF Ventures and the Australian National Reconstruction Fund Corporation.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in